Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

ETR/LLY stock hub

ETR/LLY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/LLYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

718.6B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/LLY

In the news

Latest news · ETR/LLY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.4

P25 12.3P50 15.7P75 20.2

Trailing P/E32.8

P25 16.4P50 20.9P75 30.4

ROE107.5

P25 -6.7P50 8.5P75 17.2

ROIC41.9

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/LLY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	50,000
Employees Change	3,000%
Employees Change Percent	6.38
Enterprise value	EUR 750.5B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	US5324571083
Last refreshed	2026-05-10
Market cap	EUR 718.6B
Price	EUR 810
Price currency	EUR
Rev Per Employee	1,253,231.15x
Sector	Healthcare
Sic	2834
Symbol	etr/LLY
Website	https://www.lilly.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.05%
EV Earnings	34.24x
EV/EBIT	25.85x
EV/EBITDA	24.25x
EV/FCF	73.19x
EV/Sales	12.23x
FCF yield	1.43%
Forward P/E	25.41x
P/B ratio	26.56x
P/E ratio	32.78x
P/S ratio	11.47x
PE Ratio10 Y	52.61x
PE Ratio3 Y	73.78x
PE Ratio5 Y	62.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	47.3%
EBITDA Margin	50.13%
FCF margin	16.36%
Gross margin	82.83%
Gross Profit	EUR 51.9B
Gross Profit Growth	49.48%
Gross Profit Growth Q	54.44%
Gross Profit Growth3 Y	40.65%
Gross Profit Growth5 Y	25.35%
Net Income	EUR 21.9B
Net Income Growth	127.6%
Net Income Growth Q	168.07%
Net Income Growth Quarters	10%
Net Income Growth Years	2%
Net Income Growth3 Y	64.42%
Net Income Growth5 Y	32.92%
Pretax Margin	43.08%
Profit Margin	34.99%
Profit Per Employee	EUR 438,455
Profitable Years	8
ROA	20.74
Roa5y	13.51
ROCE	42.75
ROE	107.5
Roe5y	74.21
ROIC	41.92
Roic5y	35.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	30.86%
Cagr15y	28.65%
Cagr1y	19.33%
Cagr3y	28.43%
Cagr5y	39.56%
Div CAGR10	11.52%
Div CAGR3	11.35%
Div CAGR5	15.28%
EPS Growth	129.1
EPS Growth Q	169.9
EPS Growth Quarters	10
EPS Growth Years	2
EPS Growth3 Y	64.8
EPS Growth5 Y	33.34
FCF Growth	216.44%
FCF Growth Q	1,827.56%
FCF Growth3 Y	36.63%
FCF Growth5 Y	13.11%
OCF Growth	119.79%
OCF Growth Q	220.11%
OCF Growth10 Y	21.88%
OCF Growth3 Y	44.46%
OCF Growth5 Y	21.25%
Revenue Growth	47.44x
Revenue Growth Q	55.54x
Revenue Growth Quarters	12x
Revenue Growth Years	8x
Revenue Growth3 Y	37.67x
Revenue Growth5 Y	23.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.7
Assets	EUR 101.1B
Cash	EUR 4.6B
Current Assets	EUR 46.5B
Current Liabilities	EUR 31.1B
Debt	EUR 37.6B
Debt EBITDA	EUR 1.19
Debt Equity	EUR 1.39
Debt FCF	EUR 3.67
Equity	EUR 27.1B
Interest Coverage	388.3
Liabilities	EUR 74B
Long Term Assets	EUR 54.6B
Long Term Liabilities	EUR 43B
Net Cash	EUR -32.6B
Net Cash By Market Cap	EUR -4.54
Net Debt EBITDA	EUR 1.04
Net Debt Equity	EUR 1.21
Net Debt FCF	EUR 3.18
Tangible Book Value	EUR 15.3B
Tangible Book Value Per Share	EUR 17.18
WACC	6.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.5
Inventory Turnover	1.04
Net Working Capital	EUR 14.7B
Quick ratio	0.72
Working Capital	EUR 15.8B
Working Capital Turnover	EUR 4.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.57%
Dividend Growth	6.52%
Dividend Growth Years	12%
Dividend per share	EUR 5.37
Dividend Years	29
Dividend Yield	0.66%
Ex Div Date	2026-02-13
Last Dividend	EUR 1.46
Payout Frequency	Quarterly
Payout Ratio	22.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,371.84%
1Y total return	19.31%
200-day SMA	783.4
3Y total return	111.86%
50-day SMA	811.4
50-day SMA vs 200-day SMA	50over200
5Y total return	429.32%
All Time High	971.1
All Time High Change	-16.62%
All Time High Date	2026-01-08
All Time Low	0.25
All Time Low Change	323,780%
All Time Low Date	2008-11-14
ATR	22.79
Beta	0.48
Ch YTD	-11.66
High	833.5
High52	971.1
High52 Date	2026-01-08
High52ch	-16.62%
Low	809.7
Low52	535.8
Low52 Date	2025-08-11
Low52ch	51.12%
Ma50ch	-0.21%
Price vs 200-day SMA	3.36%
RSI	52.56
RSI Monthly	56.23
RSI Weekly	49.59
Sharpe ratio	0.62x
Sortino ratio	1.05
Total Return	1.24%
Tr YTD	-11.51
Tr15y	4,277.37%
Tr1m	1.68%
Tr1w	-1.53%
Tr3m	-8.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 29.6B
Operating Income Growth	74.29
Operating Income Growth Q	84.42
Operating Income Growth3 Y	64.3
Operating Income Growth5 Y	36.9
Operating margin	47.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	889,347,313%
Net Borrowing	3,785,302,368
Shares Insiders	0.17%
Shares Institutions	90.01%
Shares Qo Q	-0.23%
Shares Yo Y	-0.57%
Short Ratio	2.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 9.7B
Average Volume	1,782.8x
Bv Per Share	30.28
CAPEX	EUR -7.5B
Ch10y	1,145.7
Ch15y	2,967
Ch1m	1.68
Ch1w	-1.53
Ch1y	18.43
Ch3m	-8.93
Ch3y	107.2
Ch5y	403.5
Ch6m	3.02
Change	-2.02%
Change From Open	-2.25
Close	826.4
Days Gap	0.23
Depreciation Amortization	1,732,386,366
Dollar Volume	683,386.8
Earnings Date	2026-04-30
EBIT	EUR 29.6B
EBITDA	EUR 31.4B
EPS	EUR 24.42
F Score	6
FCF	EUR 10.3B
FCF EV Yield	1.37x
Financing CF	-6,125,739,900
Fiscal Year End	December
Founded	1,876
Goodwill	5,198,007,060
Graham Number	130.17962
Graham Upside	-83.92
Income Tax	EUR 5.1B
Investing CF	-10,004,305,500
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	EUR 618
Lynch Upside	-23.73
Ma150	835.5
Ma150ch	-3.08%
Ma20	787.1
Ma20ch	2.87%
Net CF	1,898,519,700
Open	828.3
P FCF Ratio	70.08
P OCF Ratio	40.45
Payment Date	2026-03-10
Position In Range	0
Ppne	22,504,911,480
Price Date	2026-05-08
Price EBITDA	EUR 22.88
Ptbv Ratio	46.82
Relative Volume	0.49x
Revenue	62,661,557,700x
SBC By Revenue	0.88x
Share Based Comp	549,000,900
Tax By Revenue	8.09x
Tax Rate	18.79%
Tr6m	3.34%
Volume	844
Z Score	7.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/LLY dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$5.37 annual per share

Payout ratio

+22.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+15.3%

12 consecutive years of growth

Total shareholder yield

+1.2%

Next ex-dividend date: 2026-02-13

Performance

ETR/LLY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/LLY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.0%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETR/LLY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.6

Neutral momentum band

Price vs 200-day MA

+3.4%

50/200-day relationship not available

Beta (5Y)

0.48

Less volatile than the market

Sharpe ratio

0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/LLY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/LLY stock rating?

etr/LLY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/LLY analysis?

The full report lives at /stocks/etr/LLY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/LLY?

The latest report frames etr/LLY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/LLY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.